718 related articles for article (PubMed ID: 15833188)
41. Megakaryocyte progenitors in immune thrombocytopenic purpura (ITP).
Podolak-Dawidziak M
Thromb Res; 1991 Apr; 62(1-2):93-6. PubMed ID: 1853310
[TBL] [Abstract][Full Text] [Related]
42. Thrombopoiesis- and megakaryocyte colony-stimulating factors in the urine of patients with idiopathic thrombocytopenic purpura.
Kawakita M; Enomoto K; Katayama N; Kishimoto S; Miyake T
Br J Haematol; 1981 Aug; 48(4):609-15. PubMed ID: 6974002
[TBL] [Abstract][Full Text] [Related]
43. Megakaryocyte growth in vitro predicts outcome in idiopathic thrombocytopenic purpura.
Gerritsma H; Schmid A; Luethy AR; Leibundgut K; Gugler E; Wagner HP; Hirt A
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):194-9. PubMed ID: 8037336
[TBL] [Abstract][Full Text] [Related]
44. CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia.
Huang J; Wang Z; Huang L; Zheng M
Leuk Res; 2018 Mar; 66():15-19. PubMed ID: 29353154
[TBL] [Abstract][Full Text] [Related]
45. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
46. Detection of a primitive megakaryocyte progenitor cell in human fetal bone marrow.
Bruno E; Murray LJ; DiGiusto R; Mandich D; Tsukamoto A; Hoffman R
Exp Hematol; 1996 Mar; 24(4):552-8. PubMed ID: 8608806
[TBL] [Abstract][Full Text] [Related]
47. Direct infection of colony forming unit-megakaryocyte by human cytomegalovirus contributes the pathogenesis of idiopathic thrombocytopenic purpura.
Xiao Y; Lin W; Liu Q; Jin R; Fei H
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):555-7. PubMed ID: 17219966
[TBL] [Abstract][Full Text] [Related]
48. Kinetics of megakaryocyte progenitor cells in idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Nomura T
Blut; 1990 Nov; 61(5):303-6. PubMed ID: 2271777
[TBL] [Abstract][Full Text] [Related]
49. Lack of compensatory megakaryocytopoiesis in HIV-1-seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients.
Zauli G; Re MC; Gugliotta L; Visani G; Vianelli N; Furlini G; La Placa M
AIDS; 1991 Nov; 5(11):1345-50. PubMed ID: 1768383
[TBL] [Abstract][Full Text] [Related]
50. Study of megakaryocytic progenitors (CFU-MK) in human long-term bone marrow cultures (LTBMC): adjuvant effect of plasma from aplastic patients.
Chauvet M; Léger J; Molina L; Chabannon C; Hollard D
Exp Hematol; 1990 Jan; 18(1):61-4. PubMed ID: 2298271
[TBL] [Abstract][Full Text] [Related]
51. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies.
Hoffman R; Bruno E; Elwell J; Mazur E; Gewirtz AM; Dekker P; Denes AE
Blood; 1982 Nov; 60(5):1173-8. PubMed ID: 6982086
[TBL] [Abstract][Full Text] [Related]
52. [Expression levels of CXCR4 on megakaryocytes and its ligand in bone marrow in children with acute idiopathic thrombocytopenic purpura].
Sheng GY; Huang XL; Bai ST
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):499-501. PubMed ID: 15324566
[TBL] [Abstract][Full Text] [Related]
53. Complement-dependent cytotoxic factor to megakaryocyte progenitors in sera from patients with idiopathic thrombocytopenic purpura.
Usuki Y; Kohsaki M; Nagai K; Ohe Y; Hara H
Int J Cell Cloning; 1986 Nov; 4(6):447-63. PubMed ID: 3782893
[TBL] [Abstract][Full Text] [Related]
54. [Study on the pathogenesis of acquired pure amegakaryocytic thrombocytopenic purpura].
Lu D; Chen Y; Ding R
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):124-6. PubMed ID: 11601236
[TBL] [Abstract][Full Text] [Related]
55. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
56. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K
Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514
[TBL] [Abstract][Full Text] [Related]
57. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
[TBL] [Abstract][Full Text] [Related]
58. Megakaryocyte apoptosis in immune thrombocytopenia.
Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
[TBL] [Abstract][Full Text] [Related]
59. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
60. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
